The complexity and heterogeneity of protein therapeutics present significant challenges in biologics discovery, as ...

In therapeutic antibody development the fragment crystallizable (Fc) region is far more than just an antigen-binding aid; it's role is much larger, functioning as the antibody’s functional control ...

Alzheimer's disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a ...

Discover biohacking explained with essential wellness safe practices and practical health tips to safely optimize your body ...

Enterprise finance and IT leaders can lay the groundwork to adopt artificial intelligence and drive operational efficiency.

Around 10 million new cases of dementia are diagnosed globally every year, with Alzheimer’s disease accounting for 60-70% of ...

While some practices remain controversial or speculative, biohackers are united by a shared curiosity: how can we engineer ...

MicroCloud Hologram Inc. (NASDAQ: HOLO), ('HOLO” or the 'Company'), a technology service provider, proposed a Quantum Convolutional Neural Network (QCNN) based on hybrid quantum-classical learning and ...